Inpatient management of sickle cell pain: A 'snapshot' of current practice

American Journal of Hematology

Volumn 87, Issue 3, 2012, Pages 333-336

  Miller, Scott T ^a,b   Kim, Hae Young ^b   Weiner, Debra ^c   Wager, Carrie G ^b   Gallagher, Dianne ^b   Styles, Lori ^d   Dampier, Carlton D ^e  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d CHILDREN S HOSPITAL OAKLAND   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROMORPHONE; HYDROXYUREA; MORPHINE; OPIATE; SECRETORY PHOSPHOLIPASE A2;

ABDOMINAL PAIN; ACUTE CHEST SYNDROME; BACKACHE; BREATHING RATE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LETTER; MEDICAL HISTORY; OXYGEN SATURATION; PAIN; PATIENT CARE; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; SEPSIS; SICKLE CELL; SPIROMETRY; THORAX PAIN; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; AGED; ANALGESIA, PATIENT-CONTROLLED; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DRUG UTILIZATION; FEASIBILITY STUDIES; FEMALE; FLUID THERAPY; HUMANS; HYDROXYUREA; INPATIENTS; MALE; MIDDLE AGED; NARCOTICS; OXYGEN INHALATION THERAPY; PAIN; PHYSICIAN'S PRACTICE PATTERNS; PULMONARY EDEMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SPIROMETRY; YOUNG ADULT;

EID: 84862777383     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22265     Document Type: Letter

References (19)

1. Styles LA, Aarsman AJ, Vichinsky EP, et al. Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease. Blood 2000; 96: 3276-3278.
2. Styles LA, Abboud M, Larkin S, et al. Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol 2007; 136: 343-344.
3. Bellet PS, Kalinyak KA, Shukla R, et al. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med 1995; 333: 699-703.
4. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991; 325: 11-16.
5. Charache S, Scott JC, Charache P. "Acute chest syndrome" in adults with sickle cell anemia. Microbiology, treatment, and prevention. Arch Intern Med 1979; 139: 67-69.
6. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000; 342: 1855-1865.
7. Panepinto JA, Brousseau DC, Hillery CA, et al. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer 2005; 44: 182-186.
8. Ellison AM, Bauchner H. Socioeconomic status and length of hospital stay in children with vaso-occlusive crises of sickle cell disease. J Natl Med Assoc 2007; 99: 192-196.
9. Crabtree EA, Mariscalco MM, Hesselgrave J, et al. Improving care for children with sickle cell disease/acute chest syndrome. Pediatrics; 127: e480-e488.
10. Dampier CD, Smith WR, Kim HY, et al. Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: A phase III analgesic trial for hospitalized sickle cell patients with painful episodes. Am J Hematol.
11. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995; 332: 1317-1322.
12. Brawley OW, Cornelius LJ, Edwards LR, et al. National Institutes of Health Consensus Development Conference statement: Hydroxyurea treatment for sickle cell disease. Ann Intern Med 2008; 148: 932-938.
13. Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood 2010; 115: 5300-5311.
14. Wang WC, Ware RE, Miller ST, et al. A multicenter randomised controlled trial of hydroxyurea (hydroxycarbamide) in very young children with sickle cell anaemia. Lancet 2011;337:1663-1672.
15. Ballas SK, Bauserman RL, McCarthy WF, et al. Utilization of analgesics in the multicenter study of hydroxyurea in sickle cell anemia: effect of sex, age, and geographical location. Am J Hematol 2010; 85: 613-616.
16. Radel EG, Kochen JA, Finberg L. Hyponatremia in sickle cell disease. A renal salt-losing state. J Pediatr 1976; 88: 800-805.
17. Haynes J, Jr., Allison RC. Pulmonary edema. Complication in the management of sickle cell pain crisis. Am J Med 1986; 80: 833-840.
18. Hooker EA, Danzl DF, Brueggmeyer M, et al. Respiratory rates in pediatric emergency patients. J Emerg Med 1992; 10: 407-410.
19. Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics 1957; 19: 823-832.